We are live on ! Find out more
CCM

CAAS Capital Management Portfolio holdings

AUM $934M
1-Year Est. Return 1.45%
This Fund
S&P 500
This Quarter Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
AUM
$10.5B
AUM Growth
+$6.2B
Cap. Flow
+$4.78B
Cap. Flow %
45.54%
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171

Sector Composition

Rank Sector Weight
1 Technology 7.01%
2 Healthcare 6.25%
3 Communication Services 2.7%
4 Consumer Discretionary 2.07%
5 Financials 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSX icon
701
Biodesix
BDSX
$228M
$403K ﹤0.01%
+1,000
New +$311K
ABCL icon
702
AbCellera Biologics
ABCL
$1.78B
$402K ﹤0.01%
+10,000
New +$457K
RCL icon
703
CALL
Royal Caribbean
RCL
$86.7B
$396K ﹤0.01%
+5,300
New +$369K
RCL icon
704
PUT
Royal Caribbean
RCL
$86.7B
$381K ﹤0.01%
+5,100
New +$356K
FOLD
705
DELISTED
Amicus Therapeutics
FOLD
$371K ﹤0.01%
+16,049
New +$328K
PENN icon
706
CALL
PENN Entertainment
PENN
$2.67B
$371K ﹤0.01%
+4,300
New +$307K
HOUS
707
DELISTED
Anywhere Real Estate
HOUS
$367K ﹤0.01%
+28,000
New +$334K
GCO icon
708
Genesco
GCO
$435M
$365K ﹤0.01%
+12,127
New +$310K
SOFIW
709
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
$353K ﹤0.01%
+100,000
New +$276K
WYNN icon
710
Wynn Resorts
WYNN
$10.2B
$338K ﹤0.01%
+3,000
New +$277K
BMY.RT
711
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$338K ﹤0.01%
489,170
ROKU icon
712
Roku
ROKU
$21.6B
$332K ﹤0.01%
1,000
-1,000
-50% -$262K
NMMCU
713
DELISTED
North Mountain Merger Corp. Unit
NMMCU
$322K ﹤0.01%
30,000
AGC
714
DELISTED
Altimeter Growth Corp
AGC
$322K ﹤0.01%
+25,000
New +$320K
SYF icon
715
Synchrony
SYF
$25.3B
$316K ﹤0.01%
+9,100
New +$274K
PXD
716
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
$308K ﹤0.01%
2,700
FVAM
717
DELISTED
5:01 Acquisition Corp
FVAM
$305K ﹤0.01%
+30,000
New +$303K
FHTX icon
718
Foghorn Therapeutics
FHTX
$271M
$304K ﹤0.01%
+15,000
New +$287K
FVRR icon
719
Fiverr
FVRR
$340M
$303K ﹤0.01%
+1,553
New +$281K
TDOC icon
720
CALL
Teladoc Health
TDOC
$1.21B
$300K ﹤0.01%
1,500
DXCM icon
721
CALL
DexCom
DXCM
$32.9B
$296K ﹤0.01%
3,200
CALC icon
722
CalciMedica
CALC
$11.9M
$290K ﹤0.01%
714
OMER icon
723
Omeros
OMER
$909M
$286K ﹤0.01%
20,015
-44,958
-69% -$549K
PACE.U
724
DELISTED
TPG Pace Tech Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fifth
PACE.U
$284K ﹤0.01%
+25,000
New +$263K
ALGS icon
725
Aligos Therapeutics
ALGS
$28.5M
$277K ﹤0.01%
+400
New +$195K

Similar funds

CAAS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.

  • CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
  • CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
  • CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
  • CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
  • CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
  • CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
  • CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.